Market closed
Access this stock data via API
Subscribe
Eql Pharma AB
0
0
0%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 107.2M 113.3M 92.2M 85.2M
Cost of revenue 61.1M 66.7M 54.5M 50.5M
Gross profit 46.2M 46.5M 37.7M 34.7M
Operating expense
Research & development 2.8M 2.4M 2.7M 2.9M
Selling general and admin 23.9M 21.2M 20.4M 17.6M
Other operating expenses
Operating income 20.5M 23.0M 14.8M 14.3M
Non operating interest income
Income 2K 3K 2K 1K
Expense 8.1M 6.5M 2.2M 2.3M
Other income expense
Pretax income 12.4M 16.5M 12.7M 12.0M
Tax provision 2.6M 3.4M 2.6M 2.5M
Net income 9.8M 13.1M 10.1M 9.6M
Basic EPS 0.3 0.5 0.4 0.3
Diluted EPS 0.3 0.4 0.3 0.3
Basic average shares 29.1M 29.1M 29.1M 29.1M
Diluted average shares 29.9M 29.9M 29.9M 29.1M
EBITDA 20.5M 23.0M 14.8M 14.3M
Net income from continuing op. 20.5M 23.0M 14.8M 14.3M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 6 hours 13 minutes

02:46
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CET, UTC+01:00).